We are a global immunotherapy powerhouse aspiring to translate science into survival
Interest Selector
Select an area of interest to see tailored content.
- General
- Investors
- Media
- HCP
Our mission
We are committed to improving the health of people worldwide with our fundamental research and development of immunotherapies. We believe in scientific rigor, innovation and passion as driving force. BioNTech was founded by scientists and physicians to translate science into survival by combining fundamental research and operational excellence.
Therapeutic Areas
We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer and infectious diseases. As immune engineers we have a deep understanding of the underlying mechanisms that enable the immune system to effectively recognize both external threats like infectious diseases and internal threats like cancer. Our goal is to translate this expertise into therapies and vaccines that can make a difference for individuals as well as humankind.
Oncology
Cancer is a devastating disease and remains a tremendous burden worldwide. As every cancer type is unique, we believe that immunology and immunotherapy should be able to address each cancer indication in a different way. Therefore, we have established a range of technology platforms and tools to develop the best treatment options for each tumor indication.
Infectious Diseases
We believe the technology behind our COVID-19 vaccine has potential against a range of other infectious diseases and could also play an important role for future global pandemic preparedness measures. Our COVID-19 vaccine efforts have demonstrated several advantages over the traditional vaccine development that we aim to translate into new mRNA vaccine programs targeting diseases with a massive health burden such as malaria, tuberculosis and HIV.
Drug Classes
Our goal is clear: we want to provide better medicines for patients worldwide. We have four technologies in our toolbox – mRNA-based therapies, cell therapies, small molecules and antibodies –each can be utilized for specific purposes or can be even combined with each other in a synergistic manner. With this approach, we aim to provide the optimal treatment for each patient.
Clinical Trials
We strive to exploit the full potential of the body’s immune system by combining powerful new therapeutic mechanisms and a diverse array of biological targets to successfully help address cancer and infectious diseases. As part of this mission, we are conducting clinical trials to translate science into survival.
Pipeline
We apply breakthrough technologies in four different drug modalities to create tailored treatment approaches for oncology and infectious diseases ushering in a new era of immunotherapies.
Preclinical Phase
Phase 1
Phase 2
Phase 3
Careers at BioNTech
Our mission is clear: translating science into survival to improve the health of people worldwide. We are always on the lookout for dedicated and curious new talents supporting our team of visionaries, entrepreneurs, scientists, engineers and business professionals. Join us and be part of our unique pioneering spirit.
Careers at BioNTech
Our mission is clear: translating science into survival to improve the health of people worldwide. We are always on the lookout for dedicated and curious new talents supporting our team of visionaries, entrepreneurs, scientists, engineers and business professionals. Join us and be part of our unique pioneering spirit.
Connect with us
Questions about our products, services or clinical trials? Find the right contact person at our Service Center.
Connect with us
Questions about our products, services or clinical trials? Find the right contact person at our Service Center.
